This case demonstrates a patient with metastatic renal cell carcinoma who developed a severe, pruritic rash diagnosed as transient acantholytic dermatosis (TAD) following immunotherapy. Despite several unsuccessful treatments, dupilumab therapy provided substantial relief, resulting in complete resolution of the TAD symptoms and has sustained effect even after resuming immunotherapy for his cancer.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Rapid Resolution of Refractory Immunotherapy-Related Transient Acantholytic Dermatosis with Dupilumab

  • Melissa R. Laughter,
  • Ata S. Moshiri

摘要

This case demonstrates a patient with metastatic renal cell carcinoma who developed a severe, pruritic rash diagnosed as transient acantholytic dermatosis (TAD) following immunotherapy. Despite several unsuccessful treatments, dupilumab therapy provided substantial relief, resulting in complete resolution of the TAD symptoms and has sustained effect even after resuming immunotherapy for his cancer.